40
Case # 3 Slide Seminar Los Angeles Society of Pathologists March 13, 2007 Randa Alsabeh, M.D. Cedars-Sinai Medical Center

Case # 3lasop.com/pgs/hdouts/2007-03 Case 03 Cedars.pdf• Painless testicular enlargement, more bilateral then germ cell tumors (50% of bilateral testicular neoplasms are lymphomas)

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

  • Case # 3Slide Seminar

    Los Angeles Society of Pathologists

    March 13, 2007Randa Alsabeh, M.D.

    Cedars-Sinai Medical Center

  • Clinical History

    • 41 year old white male• Fevers, shaking chills, cough, shortness

    of breath• Chest X-ray: innumerable bilateral

    pulmonary nodules• Physical exam: right testicular mass

  • Differential Diagnosis

    • Low grade lymphoma with transformation to large cell lymphoma

    • NK/T-cell lymphoma

  • CD20

  • CD3

  • CD30

  • CD45

  • Bob-1

  • Oct-2

  • KAPPA

  • LAMBDA

  • Differential Diagnosis

    • Low grade lymphoma with transformation to large cell lymphoma

    • NK/T-cell lymphoma• T-cell rich large B-cell lymphoma with

    areas of Diffuse large B-cell lymphoma!

    X

    X

  • EBER

  • EBER

  • EBV positive large B-cell lymphoma consistent with lymphomatoid granulomatosis, grade 2 and 3

  • Lymphoma of the Male Genital Tract

    • Majority arise in the testes• Children: Acute leukemia (ALL)• Adults: Primary versus secondary spread

    of systemic lymphoma• Prostate, epididymis and penis: reflect

    widespread disease

  • Primary Testicular Lymphoma• 5% of all testicular malignancies• 7th to 8th decades, single most common primary

    testicular neoplasm• Painless testicular enlargement, more bilateral

    then germ cell tumors (50% of bilateral testicular neoplasms are lymphomas)

    • Patients with B symptoms are younger, bilateral disease (Burkitt lymphoma)

    • No association with previous trauma, inflammation, malformation or undescended testicle

  • Testicular Lymphoma

    • Most common diffuse large B-cell lymphoma

    • Low grade lymphomas, NK/T cell lymphoma, ALCL and angiotropic lymphoma

    • 50% have systemic disease• Relapse occurs in CNS and contralateral

    testicle

  • Lymphomatoid Granulomatosis (LYG)

    • Angiocentric and angiodestructive lymphoproliferative disorder involving extranodal sites: lung (100%), brain (26%), kidney (32%), liver (29%) and skin (25-50%)

    • Lymph nodes and spleen are rarely involved• Also known as angiocentric

    immunoproliferative lesion (AIL)• Must be distinguished from extranodal NK/T-

    cell lymphoma, nasal type

  • Lymphomatoid Granulomatosis (LYG)

    • First description: unclear whether it a neoplastic or inflammatory process, 1972 by Liebow

    • Initially misclassified as T-cell lymphoma• Clonal EBV sequences in B-cells

  • Lymphomatoid Granulomatosis (LYG)

    • Adults, M/F: 2/1• Patients with immunodeficiency

    disorders are at increased risk: HIV, allogeneic BMT, Wiskott-Aldrich syndrome, x-linked lymphoproliferative disorder

  • Lymphomatoid Granulomatosis (LYG)

    • Mixed infiltrate of small lymphocytes, histiocytes, plasma cells, and variable numbers of large atypical lymphoid cells

    • Angiocentric and angiodestructive infiltrates• EBV positive B-cells, CD30 positive in a

    background of reactive T-cells-Grade I: EBV positive cells (

  • Morphology• D.D. includes benign angiocentric

    lymphohistiocytic processes (mycobacterial or fungal infections,necrotizing sarcoidosis, and Wegener's granulomatosis)

    • True granulomas are not usually present in lymphomatoid granulomatosis

  • Why is it important to make the diagnosis?

    • A. Because hematopathologist love toclassify to justify their jobs

    • B. Because it is clinically relevant• C. All of the above

  • “The urge to classify is a fundamental human instinct; like a predisposition to sin, it accompanies us into the world at birth and stays with us to the end”Hopwood A.T.Proceedings of the Linnean of London1957;171:230-234

  • Clinically Relevant

    • Grade 1 and 2, uncertain malignant potential, waxing and waning, and may regress with interferon alfa-2b therapy and should be differentiated from T-cell rich B-cell lymphoma

    • Grade 3 considered a variant large B-cell lymphoma, treated as aggressively but clinician should be alerted to the possibility of an underlying immune deficiency status

  • Prognosis and Management

    • 27% complete remission without therapy• Majority with progressive disease with a

    median survival of 14 months• CHOP 47% response with a mean

    duration of 5.2 years• Interferon alfa-2b 67% response for

    grade 1 and 2• Rituxan

  • • Our patient was treated with CHOP/Rituxan, underwent autologous stem cell transplantation and is in complete remission with complete resolution of his lung masses

  • Thank You